Latest Blog Posts
Organoids: Revolutionising Disease Modelling
Organoids are transforming biomedical research by enabling disease modelling in 3D miniature organs grown in the lab.
<p>Organoids — miniature, self-organised 3D tissue cultures derived from stem cells — are rapidly changing how we study disease. Unlike traditional 2D cell cultures, organoids mimic the architecture and function of real organs, providing dramatically more accurate experimental models for drug testing and personalised medicine.</p><p>At NanoFludiks, we are advancing organoid engineering techniques to develop better models for gastrointestinal, liver, and pulmonary diseases. Our workshops give researchers hands-on experience building and characterising organoid systems.</p>
Multi-Omics: A Systems View of Biology
Multi-omics integrates genomics, proteomics, metabolomics, and transcriptomics to deliver a comprehensive view of biological systems.
<p>The integration of multiple omics layers — genomics, transcriptomics, proteomics, and metabolomics — is revealing biological complexity that single-dataset analysis cannot capture. Multi-omics approaches are driving breakthroughs in understanding disease mechanisms, identifying biomarkers, and developing targeted therapies.</p><p>AI and machine learning are essential tools for integrating and interpreting the enormous datasets generated by multi-omics workflows. NanoFludiks provides training in both experimental omics techniques and AI-powered data analysis.</p>
Nanofluidics in Biomanufacturing
Nanofluidic technologies are enabling unprecedented control over biological manufacturing processes at the cellular level.
<p>Nanofluidics — the science of controlling and manipulating fluids at the nanoscale — is finding increasing application in biomanufacturing. From cell sorting and encapsulation to precise delivery of growth factors, nanofluidic systems offer control that traditional bioprocess equipment cannot achieve.</p><p>NanoFludiks integrates nanofluidics into its bio-manufacturing training programs, giving participants direct experience with cutting-edge miniaturised systems.</p>
AI & Data Science in Biotechnology
Artificial intelligence is accelerating drug discovery, genomic analysis, and clinical decision support in modern biotechnology.
<p>Artificial intelligence is transforming every domain of biotechnology. Machine learning models are being used to predict protein structures, identify drug candidates, analyse multi-omics data, and automate laboratory workflows. At NanoFludiks, we train the next generation of scientists to leverage AI and data science tools in their research.</p>
Bioreactor Design for Scalable Cell Culture
Modern bioreactor systems enable scalable, controlled cell culture essential for producing biologics and cell therapies.
<p>Bioreactors are central to biomanufacturing — they provide controlled environments for growing cells and microorganisms at scale. Whether producing monoclonal antibodies, vaccines, or cell therapies, effective bioreactor design is critical to product quality and process economics.</p><p>NanoFludiks training covers stirred-tank, wave, and perfusion bioreactor systems, giving participants practical skills applicable to pharmaceutical and biotech industry roles.</p>
Infection Biology & Clinical Diagnostics
Understanding host-pathogen interactions at the molecular level is key to developing effective diagnostics and therapeutics.
<p>Infection biology explores how pathogens invade host systems, evade immune defences, and cause disease. Advances in molecular diagnostics — including PCR, CRISPR-based detection, and biosensors — are enabling faster, more accurate identification of infectious agents.</p><p>NanoFludiks research in this area, led by Prof. Rupesh Chaturvedi, focuses on multi-omics approaches to understanding infection and developing next-generation diagnostics.</p>
Spheroid Models for Drug Screening
Tumour spheroids provide physiologically relevant 3D cancer models ideal for preclinical drug screening studies.
<p>Tumour spheroids are three-dimensional aggregates of cancer cells that replicate key features of solid tumours including hypoxic cores, nutrient gradients, and drug penetration barriers. They are increasingly used in preclinical drug screening to bridge the gap between simple 2D cell culture and animal models.</p><p>NanoFludiks offers hands-on training in spheroid formation, characterisation, and drug testing assays using state-of-the-art equipment.</p>
Nanobiotechnology: Where Nano Meets Biology
Nanobiotechnology applies nanoscale materials and devices to biological systems for applications in diagnostics, therapy, and research.
<p>Nanobiotechnology sits at the intersection of nanotechnology and biology. Engineered nanoparticles, nanocomposites, and nanostructured surfaces are finding applications in drug delivery, biosensing, cell imaging, and gene therapy. NanoFludiks researchers are developing ZnO nanocomposite-based detection systems and exploring nanoparticle interactions with biological systems.</p>